GFAP and glioblastoma: In summary, this study presents compelling evidence that the GFAP-Cre; KrasG12D; APCL/+; p53L/L mouse model can promote GBM tumorigenesis, particularly when combined with the activation of the WNT/β-catenin signaling pathway.